Outcomes of 5-aminosalicylates withdrawal due to non-adherence in ulcerative colitis patients: A step toward evaluating intermittent therapy

Table 3 Subgroup analysis of results in patients with relapse, n (%)

Characteristics	Total (n = 12)
Time interval between 5-ASA withdrawal and relapse (months), median (IQR)	20.0 (12.3-52.3)
Duration time after relapse (months), median (IQR)	6.5 (0.0-46.5)
Treatment for remission in relapse
5-ASA tablet	9 (75.0)
5-ASA granule	1 (8.3)
5-ASA oral	10 (83.3)
5-ASA enema	6 (50.0)
5-ASA suppository	2 (16.7)
Sulfasalazine	0 (0.0)
Steroid	3 (25.0)
Thiopurine	1 (8.3)
Biologic agents	0 (0.0)
Surgery	0 (0.0)

5-ASA: 5-aminosalicylates; IQR: Interquartile range.